Operator Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings conference call. [Operator instructions] Please note this event is being recorded. I would now like to turn the conference ...
Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...
Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for physicians, who highly prioritized individual symptoms, according to data ...
Get an expert’s answers to common questions about how physical therapy can help with psoriatic arthritis, and learn how to get started. Living with psoriatic arthritis can mean chronic joint ...
Bosman’s surgery, as well as his psoriatic arthritis (PsA) and osteoarthritis (OA), left him unable to continue his vigorous gym workout routine. “I was looking for something that was low-impact and ...
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...
Objective: To evaluate the long-term effectiveness and tolerability of adalimumab in the treatment of psoriatic arthritis (PsA). Methods: Patients with PsA who completed a 24-week, double-blind study ...
Christopher Boerner; Chairman of the Board, Chief Executive Officer, Chief Operating Officer; Bristol-Myers Squibb Co David Elkins; Executive Vice President, Chief Financial Officer, Member of the ...
A screenshot of an X post purportedly quoting Elon Musk saying, in part, “MAGA is the future, and will, in fact, succeed in all the ways Nazi Germany failed to” is fabricated. The screenshot ...
A supportive mattress is key to better sleep, but quality sheets are still important, and they come at a much friendlier price. Whether you’re looking to stay cool or upgrade to organic cotton ...
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...